Abiba Pharmacia Profile
Key Indicators
- Authorised Capital ₹ 1.30 M
as on 25-06-2024
- Paid Up Capital ₹ 0.30 M
as on 25-06-2024
- Company Age 10 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.75 M
as on 25-06-2024
- Satisfied Charges ₹ 1.00 M
as on 25-06-2024
- Revenue 2.04%
(FY 2020)
- Profit 507.74%
(FY 2020)
- Ebitda 97.46%
(FY 2020)
- Net Worth 17.00%
(FY 2020)
- Total Assets -2.09%
(FY 2020)
About Abiba Pharmacia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹2.08 Cr. The company has closed loans amounting to ₹1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Jagpal and Sneh serve as directors at the Company.
- CIN/LLPIN
U24232CH2014PTC034927
- Company No.
034927
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jan 2014
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Abiba Pharmacia Private Limited offer?
Abiba Pharmacia Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Common Disease Medicines, Pharmaceutical Tablets, Hair Growth Medicine.
Who are the key members and board of directors at Abiba Pharmacia?
Financial Performance and Corporate Structure Insights of Abiba Pharmacia.
Abiba Pharmacia Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.04% increase. The company also saw a substantial improvement in profitability, with a 507.74% increase in profit. The company's net worth Soared by an impressive increase of 17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abiba Pharmacia?
In 2019, Abiba Pharmacia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 29 Jun 2022 | ₹1.98 Cr | Open |
Others Creation Date: 21 Dec 2017 | ₹0.95 M | Open |
Syndicate Bank Creation Date: 21 Mar 2017 | ₹1.00 M | Satisfied |
How Many Employees Work at Abiba Pharmacia?
Unlock and access historical data on people associated with Abiba Pharmacia, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abiba Pharmacia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abiba Pharmacia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
